The short answer
Slynd is a progestin-only pill containing 4 mg of drospirenone. Its FDA-approved use is preventing pregnancy in females of reproductive potential. Each pack has 24 active white tablets and 4 inactive green tablets. Because it contains no estrogen, it can be an option for people who need contraception but should avoid estrogen. It does not treat hot flashes or other menopause symptoms and is not hormone replacement therapy.
Key warnings on the current Slynd label
Slynd's current label (DailyMed, August 2026) has no boxed warning. Its warnings cover hyperkalemia (high potassium), blood clots, bone loss, cervical cancer, liver disease, ectopic pregnancy, blood sugar in people with diabetes, irregular bleeding or no bleeding, and depression.
Slynd is contraindicated with kidney impairment, adrenal insufficiency, current or past cervical cancer or progestin-sensitive cancer, liver tumors or liver impairment, and undiagnosed abnormal uterine bleeding.
Current label check
The medication-specific claims on this page were checked against these current product labels on 2026-10-03.
| Product label | Label date | Boxed warning on that label |
|---|---|---|
| Slynd (drospirenone) tablets | 2026-08-27 | None |
Established evidence
FDA-approved use
Prevention of pregnancy in females of reproductive potential. Slynd is not approved to treat any menopause symptom.
Why it comes up in perimenopause
Pregnancy remains possible until menopause is confirmed. People in their forties who need contraception but have reasons to avoid estrogen, such as migraine with aura, a history of blood clots, or smoking over 35, may discuss a progestin-only method. Other estrogen-free options include hormonal IUDs, the implant, and copper IUDs.
Established evidence
Missed tablets: what the label says
If one white active tablet is missed, take it as soon as possible and continue one tablet a day. If two or more white active tablets are missed, take the last missed tablet as soon as possible, continue one a day, and use non-hormonal backup contraception such as condoms if having sex within the next 7 days. Follow the full label instructions or a pharmacist's advice.
Established evidence
Potassium and drug interactions
Drospirenone has anti-mineralocorticoid activity and can raise potassium. The label advises checking potassium during the first cycle in people taking medicines that can raise potassium long term, such as ACE inhibitors, angiotensin receptor blockers, potassium-sparing diuretics, or regular NSAIDs.
Slynd vs menopause hormone therapy
| Feature | Slynd | Menopause hormone therapy |
|---|---|---|
| Main purpose | Prevent pregnancy | Treat menopause symptoms |
| Contains estrogen | No | Usually yes |
| Treats hot flashes | No | Yes |
Established evidence
Common side effects
- Irregular or unscheduled bleeding
- Acne
- Headache
- Breast pain
- Weight change
- Nausea
Questions to ask a healthcare professional
- Do I still need contraception at my age?
- Is a pill, IUD, or implant better for me?
- How will we know when I can stop contraception?
Questions, answered
What people ask about Slynd
Is Slynd hormone replacement therapy?+
No. Slynd is a contraceptive. It does not treat hot flashes, night sweats, or vaginal dryness.
Does Slynd have a boxed warning?+
No. Its current label has no boxed warning, but it lists important warnings including high potassium.
Does Kindr Health offer Slynd?+
This page is educational and does not state or imply availability through Kindr Health.
Kindr Health does not claim to offer Slynd on this page. Availability and prescribing are not implied.
A broader care pathway
Explore Kindr Health care
Learn how Kindr Health care pathways work. Any treatment decision is made by a licensed professional.
SOURCES & REFERENCES
Every clinical claim on this page is sourced.
- Slynd (drospirenone) tablets prescribing information (2026) — DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db32bc55-f295-4d87-9dbb-0a2f45573dcf
- The 2022 hormone therapy position statement of The North American Menopause Society (2022) — The Menopause Society (Menopause journal). pubmed.ncbi.nlm.nih.gov/35797481
This resource is educational and does not replace individualized medical advice. Do not start, stop, or change a prescription without guidance from a licensed healthcare professional.